Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by JLGeminion Dec 21, 2010 5:37pm

388 Views

Post# 17878838

RE: I'll be here - Looking Forward to It

To The Investment Club

In January, I will post in celebration of your artistry to pull the wool over investors' eyes. It is not worth the effort now due to the limited readership and I want to spend time enjoying the Season. I will make a second to document my experience of posting during 2010. There will be a small mention of the mere chance of coincidence that the correction rally and the beginning of a true market rally reflects my efforts and thick skin to accept your abuse. My only regret is that Club members will get rich despite being cheaters.

Have a Merry Christmas to all and may Santa bring you a lump of coal to the Club members.

JLGeminin

Bullboard Posts

Three stocks with strong income statements to buy right now